Milestone Scientific (NYSEAMERICAN:MLSS – Get Rating) posted its quarterly earnings data on Tuesday. The medical instruments supplier reported ($0.03) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.03), Fidelity Earnings reports. Milestone Scientific had a negative return on equity of 39.43% and a negative net margin of 79.28%.
Shares of NYSEAMERICAN MLSS opened at $0.87 on Thursday. The firm has a market cap of $59.26 million, a P/E ratio of -9.67 and a beta of 1.34. Milestone Scientific has a 1-year low of $0.75 and a 1-year high of $3.00.
A number of large investors have recently made changes to their positions in MLSS. Morgan Stanley increased its position in Milestone Scientific by 1,855.2% during the 2nd quarter. Morgan Stanley now owns 774,494 shares of the medical instruments supplier’s stock valued at $1,898,000 after buying an additional 734,883 shares in the last quarter. Sequoia Financial Advisors LLC acquired a new position in shares of Milestone Scientific in the first quarter valued at about $86,000. State Street Corp increased its holdings in shares of Milestone Scientific by 83.9% in the fourth quarter. State Street Corp now owns 87,700 shares of the medical instruments supplier’s stock valued at $181,000 after purchasing an additional 40,000 shares during the period. Barclays PLC increased its holdings in shares of Milestone Scientific by 475.6% in the fourth quarter. Barclays PLC now owns 40,842 shares of the medical instruments supplier’s stock valued at $84,000 after purchasing an additional 33,747 shares during the period. Finally, Jane Street Group LLC acquired a new position in shares of Milestone Scientific in the first quarter valued at about $35,000. 8.82% of the stock is currently owned by institutional investors.
About Milestone Scientific (Get Rating)
Milestone Scientific Inc designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic.
- Get a free copy of the StockNews.com research report on Milestone Scientific (MLSS)
- MarketBeat Podcast: Options Trading As Easy As Trading Stocks
- The TJX Companies: It’s Not All Doom And Gloom In Retail
- Simply Good Foods Stock is Simply Looking Good Down Here
- Shoe Carnival’s Q1 Results Are No Joke, Shares Fall 15%
- Analog Devices Is Ready To Scale New Highs Despite Tech Wreck
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.